Smart card platform vendor CardLogix has partnered with Innovonics, a provider of encryption hardware, to develop and market a smart card/reader product that enables users to access patient records and to make payments through a single desktop terminal.
Smart card platform vendor CardLogix has partnered with Innovonics, a provider of encryption hardware, to develop and market a smart card/reader product that enables users to access patient records and to make payments through a single desktop terminal. Encryption technology secures the transactions themselves, and access to card data is restricted by mutual authentication, which verifies patient identity and user identity to safeguard privacy and protect against fraud. The smart card stores and synchronizes data from medical records, a central database, and patient benefits status.
The combination of Innovonics PC Pay device and the CardLogix multifunction smart card platform enables clinicians as well as insurers to update medical records and process payments. In addition, clients can install the prescription application, which loads onto the card prescriptions that are then filled by an authorized pharmacy. The new product can also be integrated with installed computer systems through the Innovonics PC Pay developer kit, which includes two PC Pay devices, five smart cards, interface software, documentation, and the CardLogix Winplex API. The companies are marketing the developer kits for $789 each.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.